<DOC>
	<DOCNO>NCT02832557</DOCNO>
	<brief_summary>The goal study identify miRNAs increase decreased level saliva child autism spectrum disorder ( ASD ) developmental delay would useful biomarkers screen toddler young child ASD . These biomarkers may allow early diagnosis autism , allow early service , also help u understand change brain autistic child .</brief_summary>
	<brief_title>A Salivary miRNA Diagnostic Test Autism</brief_title>
	<detailed_description>The central aim project characterize expression microRNA ( miRNA ) saliva child autism spectrum disorder ( ASD ) . In 2012 CDC report prevalence ASD U.S. child 1 88 . Yet , biological cause , diagnosis , treatment disease remain ambiguous . Recent research suggest certain factor regulate gene expression may play role ASD . To investigate possibility plan measure small molecule call miRNAs saliva child ASD . Studies miRNAs show extruded neuron extracellular signal molecule knowledge provide new approach examine genetic regulation central nervous system . In study measure expression extracellular miRNA child ASD . Levels miRNA saliva compare normally develop control . The goal research provide possible biomarkers diagnostic screen ASD identify genetic regulatory mechanism involve ASD . The primary endpoint study follow : 1 . Characterization miRNA saliva child ASD normally develop control child two six year age . 2 . Identification miRNAs saliva predictive ASD diagnosis severity symptom . Secondary endpoint identification miRNA expression pattern correlate ASD symptom severity measure standardized neuropsychologic testing .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<criteria>Age enrollment : 2 6 year ( inclusive ) Control group : normal developmental milestone document negative ASD screen MCHATR ASD group : establish DSM5 diagnosis equivalent , capable understand and/or respond simple verbal instruction Parent/guardian must fluent spoken English ( require complete study specific questionnaire etc ) For control autistic subject study exclusion criterion include : confounding neurological ( i.e . cerebral palsy , epilepsy ) sensory ( i.e . auditory visual ) impairment . history extreme preterm birth ( &lt; 32 week gestation ) ward state Autistic subject know syndromic autism ( attribute know genetic mutation ) Control subject exclusion criterion include : A diagnosis autism developmental delay Family history ASD first degree relative</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Autism</keyword>
	<keyword>Asperger 's Syndrome</keyword>
	<keyword>microRNA</keyword>
	<keyword>epigenetic</keyword>
	<keyword>biomarker</keyword>
</DOC>